4D Molecular Therapeutics...

NASDAQ: FDMT · Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.20
-1.03%
After-hours: Aug 15, 2025, 05:36 PM EDT

4D Molecular Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-160.87M -100.84M -107.49M -71.32M
Depreciation & Amortization
6.71M 5.75M 3.88M 3.02M
Stock-Based Compensation
26.12M 19.66M 17.12M 13.8M
Other Working Capital
-334K -266K 255K -14.72M
Other Non-Cash Items
-7.08M -999K 1.14M 898K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
537K 630K -1.34M -15.53M
Operating Cash Flow
-134.59M -75.79M -86.69M -69.13M
Capital Expenditures
-3.79M -2.77M -11.54M -9.11M
Cash Acquisitions
n/a n/a 11.54M 9.11M
Purchase of Investments
-467.65M -54.8M -153.31M -168.57M
Sales Maturities Of Investments
169M n/a 147.8M 5M
Other Investing Acitivies
n/a 173.29M -11.54M -9.11M
Investing Cash Flow
-302.44M 115.72M -17.05M -172.68M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.84M 8.49M 3.08M 3.79M
Financial Cash Flow
337.25M 156.83M 3.08M 118.09M
Net Cash Flow
-99.77M 196.76M -100.65M -123.72M
Free Cash Flow
-138.37M -78.56M -98.22M -78.24M